In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 10th, 2008 | 28 | Yes |
Popular Name: Amlodipine Amlodipine
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 103129-81-3 , 103129-82-4 , 111470-99-6 , 111470-99-6; 88150-42-9 , 246852-12-0 , 88150-42-9 , 88150-47-4 , 88150-62-3 , [111470-99-6] , [246852-12-0] , [88150-42-9] , [88150-47-4]
3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
111470-99-6; Amlodipine besilate (JP16); Amlodipine besylate (USAN); D00615; Norvasc (TN)
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
88150-42-9; Amlodipine (INN); D07450; Norvasc (TN)
88150-42-9; Amlodipine; C06825
AMLODIPINE BASE; CPD000469198; SAM001246705
Amlodipine besilate;Amlodipine besylate;AMVAZ;Istin;Norvasc;Pelmec;Racemic Amlodipine
amlodipine; amlodipino; amlodipinum
Amlodipine; CPD000469198; SAM001246705
AMVAZ;Amlodipine besilate;Amlodipine besylate;Istin;Norvasc;Pelmec;Racemic Amlodipine
FDA); Amlodipine Besilate (JAN); Amlodipine Besylate (FDA
INN); Amlodipine Besilate (JAN); Amlodipine Besylate (FDA
UK-4834026; UK-48340-26; UK-4834011; UK-48340-11
USAN); Amlodipine Besilate (JAN)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.58 | 7.61 | -60.61 | 4 | 7 | 1 | 102 | 409.89 | 10 | ↓ |
Hi High (pH 8-9.5) | 2.58 | 7.17 | -11.79 | 3 | 7 | 0 | 100 | 408.882 | 10 | ↓ |
Hi High (pH 8-9.5) | 1.83 | 6.31 | -39.43 | 2 | 7 | -1 | 106 | 407.874 | 9 | ↓ |
Hi High (pH 8-9.5) | 1.83 | 6.3 | -37.5 | 2 | 7 | -1 | 106 | 407.874 | 9 | ↓ |
Hi High (pH 8-9.5) | 1.83 | 6.17 | -40.72 | 2 | 7 | -1 | 106 | 407.874 | 9 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 198-200° | Matrix Scientific |
ALOGPS_SOLUBILITY | 7.40e-03 g/l | DrugBank-approved |
Purity | 99% | APIChem |
Purity | >95% | Matrix Scientific |
Indications | antihypertensive | KeyOrganics Bioactives |
Therapy | Ca channel blocker | SMDC Iconix |
Target | Calcium Channel | Selleck Chemicals |
Warnings | IRRITANT | Matrix Scientific |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP05624a | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP05624a | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2344 | 0.28 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 7943 | 0.26 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5370 | 0.26 | Binding ≤ 10μM |
CAC1C-1-E | Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.43 | Binding ≤ 10μM |
CAC1C-1-E | Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Functional ≤ 10μM |
CAC1D-1-E | Voltage-gated L-type Calcium Channel Alpha-1D Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Functional ≤ 10μM |
CAC1E-1-E | Voltage-gated R-type Calcium Channel Alpha-1E Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Functional ≤ 10μM |
CAC1S-1-E | Voltage-gated L-type Calcium Channel Alpha-1S Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.40 | Functional ≤ 10μM |
Z101865-1-O | Leishmania Chagasi (cluster #1 Of 1), Other | Other | 5350 | 0.26 | Functional ≤ 10μM |
Z50457-1-O | Leishmania Amazonensis (cluster #1 Of 3), Other | Other | 2930 | 0.28 | Functional ≤ 10μM |
Z50458-3-O | Leishmania Braziliensis (cluster #3 Of 4), Other | Other | 3130 | 0.28 | Functional ≤ 10μM |
Z50460-3-O | Leishmania Major (cluster #3 Of 4), Other | Other | 3350 | 0.27 | Functional ≤ 10μM |
Z50466-1-O | Trypanosoma Cruzi (cluster #1 Of 8), Other | Other | 8070 | 0.25 | Functional ≤ 10μM |
Z50592-3-O | Oryctolagus Cuniculus (cluster #3 Of 8), Other | Other | 3 | 0.43 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 3 | 0.43 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CAC1C_RAT | P22002 | Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat | 2 | 0.43 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 2344 | 0.28 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 7943 | 0.26 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 5370 | 0.26 | Binding ≤ 10μM |
CAC1C_RAT | P22002 | Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat | 2 | 0.43 | Binding ≤ 10μM |
Z50457 | Z50457 | Leishmania Amazonensis | 2930 | 0.28 | Functional ≤ 10μM |
Z50458 | Z50458 | Leishmania Braziliensis | 3130 | 0.28 | Functional ≤ 10μM |
Z101865 | Z101865 | Leishmania Chagasi | 2610 | 0.28 | Functional ≤ 10μM |
Z50460 | Z50460 | Leishmania Major | 3350 | 0.27 | Functional ≤ 10μM |
Z50592 | Z50592 | Oryctolagus Cuniculus | 3 | 0.43 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 2.5 | 0.43 | Functional ≤ 10μM |
Z50466 | Z50466 | Trypanosoma Cruzi | 8070 | 0.25 | Functional ≤ 10μM |
CAC1C_RAT | P22002 | Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat | 1.99526231 | 0.44 | Functional ≤ 10μM |
CAC1D_RAT | P27732 | Voltage-gated L-type Calcium Channel Alpha-1D Subunit, Rat | 1.99526231 | 0.44 | Functional ≤ 10μM |
CAC1S_RAT | Q02485 | Voltage-gated L-type Calcium Channel Alpha-1S Subunit, Rat | 1.99526231 | 0.44 | Functional ≤ 10μM |
CAC1E_RAT | Q07652 | Voltage-gated R-type Calcium Channel Alpha-1E Subunit, Rat | 1.99526231 | 0.44 | Functional ≤ 10μM |
Description | Species |
---|---|
Adrenoceptors | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events |